A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
Clinical trial NCT03852498 · COMPLETED
Trial details
- NCT number
- NCT03852498
- Sponsor
- Genetix Biotherapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2023-07-24
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.